Canaccord Genuity Reiterates a 'Buy' on Amarin Corporation (AMRN); Clinical, IP, Market Takeaways From Call With AMRN Management;
Tweet Send to a Friend
Canaccord Genuity reiterates a 'Buy' on Amarin Corporation (NASDAQ: AMRN), PT $11.
Canaccord analyst says, "Reiterating rating and PT on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst says, "Reiterating rating and PT on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
